J. D’Souza

899 total citations
18 papers, 675 citations indexed

About

J. D’Souza is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, J. D’Souza has authored 18 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 9 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in J. D’Souza's work include Pharmacological Effects and Toxicity Studies (8 papers), Epilepsy research and treatment (5 papers) and Treatment of Major Depression (3 papers). J. D’Souza is often cited by papers focused on Pharmacological Effects and Toxicity Studies (8 papers), Epilepsy research and treatment (5 papers) and Treatment of Major Depression (3 papers). J. D’Souza collaborates with scholars based in Canada, United States and Switzerland. J. D’Souza's co-authors include Peter Mesenbrink, L. D. Kramer, Ahmad Beydoun, Gérard Flesch, Edwin Walker, Christian E. Elger, Y. Sturm, A. Scaramelli, Angela Moore and Ludwig Kramer and has published in prestigious journals such as Neurology, Journal of Affective Disorders and Epilepsia.

In The Last Decade

J. D’Souza

18 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. D’Souza Canada 10 548 464 178 92 51 18 675
Graham J. Schapel Australia 14 377 0.7× 349 0.8× 144 0.8× 54 0.6× 28 0.5× 27 589
J. Hardenberg Sweden 7 309 0.6× 208 0.4× 240 1.3× 45 0.5× 23 0.5× 11 458
Alain Vuong United States 17 564 1.0× 522 1.1× 101 0.6× 49 0.5× 25 0.5× 25 710
Shingo Ono Japan 13 270 0.5× 90 0.2× 66 0.4× 53 0.6× 70 1.4× 39 494
C. L. P. Deckers Netherlands 14 686 1.3× 566 1.2× 325 1.8× 100 1.1× 40 0.8× 22 828
Giulia Loiacono Italy 11 215 0.4× 191 0.4× 63 0.4× 35 0.4× 25 0.5× 18 332
R. Palm Sweden 11 162 0.3× 187 0.4× 151 0.8× 38 0.4× 42 0.8× 20 742
Shigeko Nishimura Japan 7 209 0.4× 139 0.3× 172 1.0× 42 0.5× 24 0.5× 15 362
Sudad Jawad United Kingdom 8 467 0.9× 427 0.9× 227 1.3× 100 1.1× 27 0.5× 14 642
Robert Flamini United States 12 584 1.1× 310 0.7× 323 1.8× 32 0.3× 496 9.7× 21 957

Countries citing papers authored by J. D’Souza

Since Specialization
Citations

This map shows the geographic impact of J. D’Souza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. D’Souza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. D’Souza more than expected).

Fields of papers citing papers by J. D’Souza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. D’Souza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. D’Souza. The network helps show where J. D’Souza may publish in the future.

Co-authorship network of co-authors of J. D’Souza

This figure shows the co-authorship network connecting the top 25 collaborators of J. D’Souza. A scholar is included among the top collaborators of J. D’Souza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. D’Souza. J. D’Souza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Silberstein, SD, et al.. (2008). Oxcarbazepine in migraine headache. Neurology. 70(7). 548–555. 58 indexed citations
2.
Flesch, Gérard, et al.. (2002). Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 40(11). 524–532. 9 indexed citations
3.
Sachdeo, Rajesh, Ahmad Beydoun, Steven C. Schachter, et al.. (2001). Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology. 57(5). 864–871. 74 indexed citations
4.
Beydoun, Ahmad, Rǎjesh C. Sachdeo, William E. Rosenfeld, et al.. (2000). Oxcarbazepine monotherapy for partial-onset seizures. Neurology. 54(12). 2245–2251. 117 indexed citations
5.
Walker, Edwin, Christian E. Elger, A. Scaramelli, et al.. (2000). Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy. Epilepsia. 41(12). 1597–1607. 175 indexed citations
6.
Glauser, Tracy A., M. A. Nigro, Rajesh Sachdeo, et al.. (2000). Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology. 54(12). 2237–2244. 134 indexed citations
7.
Chouinard, G, N.P.V. Nair, Stan Kutcher, et al.. (1994). A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. Journal of Affective Disorders. 32(2). 105–114. 13 indexed citations
8.
Davis, Bárbara, Sidney H. Kennedy, J. D’Souza, et al.. (1994). Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa.. PubMed. 19(4). 282–8. 4 indexed citations
9.
Bakish, David, et al.. (1993). Reversible monoamine oxidase-A inhibitors in panic disorder.. PubMed. 16 Suppl 2. S77–82. 19 indexed citations
10.
Bakish, David, et al.. (1992). BROFAROMINE AND CLOMIPRAMINE IN PANIC DISORDER: A DOUBLE-BLIND STUDY.. Clinical Neuropharmacology. 15. 60B–60B. 3 indexed citations
11.
Nair, N.P.V., Stan Kutcher, David Bakish, et al.. (1992). EFFICACY AND SAFETY OF BROFAROMINE IN DEPRESSION: A CANADIAN MULTICENTER PLACEBO CONTROLLED TRIAL AND A REVIEW OF COMPARATIVE CONTROLLED STUDIES. Clinical Neuropharmacology. 15. 426A–427A. 3 indexed citations
12.
Hesslein, Peter S., et al.. (1985). 376 AGE-DEPENDENT VERAPAMIL KINETICS AFFECT PEDIATRIC ORAL DOSE REQUIREMENTS. Pediatric Research. 19(4). 173A–173A. 1 indexed citations
13.
Damani, L. A., et al.. (1982). Species differences in the metabolicC- andN-oxidation, andN-methylation of [14C]pyridinein vivo. Xenobiotica. 12(8). 527–534. 29 indexed citations
14.
D’Souza, J., John Caldwell, & Robert L. Smith. (1980). Species variations in theN-methylation and quaternization of [14C]pyridine. Xenobiotica. 10(2). 151–157. 28 indexed citations
15.
Bevan, David R., et al.. (1980). Clinical pharmacokinetics of fazadinium. Anaesthesia. 35(9). 873–878. 1 indexed citations
16.
Caldwell, John, J. D’Souza, & R. L. Smith. (1980). Species variations in the N-methylation and quaternization of [14C]-pyridine in vivo [proceedings].. PubMed. 68(1). 119P–119P. 3 indexed citations
17.
Bevan, David R., John Caldwell, J. D’Souza, & Robert L. Smith. (1978). Influence of impaired renal function on the disposition of [14C]fazadinium in the anaesthetized greyhound [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 64(3). 402P–403P. 2 indexed citations
18.
D’Souza, J., et al.. (1977). Absorption of chloramphenicol by various routes of administration.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 65(4). 549–53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026